rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
2009-4-1
|
pubmed:abstractText |
Sitaxentan inhibits the metabolism of warfarin, resulting in a need for adjustment of warfarin dose when both drugs are coadministered. We report the long-term effects on bleeding of acenocoumarol co-administered as part of conventional therapy for pulmonary hypertension with sitaxentan in a subset of patients enrolled in the Sitaxentan To Relieve ImpaireD Exercise-3 (STRIDE-3) study.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1365-2362
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
39 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
14-8
|
pubmed:meshHeading |
pubmed-meshheading:19335742-Acenocoumarol,
pubmed-meshheading:19335742-Adolescent,
pubmed-meshheading:19335742-Adult,
pubmed-meshheading:19335742-Anticoagulants,
pubmed-meshheading:19335742-Antihypertensive Agents,
pubmed-meshheading:19335742-Drug Administration Schedule,
pubmed-meshheading:19335742-Drug Interactions,
pubmed-meshheading:19335742-Female,
pubmed-meshheading:19335742-Hemorrhage,
pubmed-meshheading:19335742-Humans,
pubmed-meshheading:19335742-Hypertension, Pulmonary,
pubmed-meshheading:19335742-International Normalized Ratio,
pubmed-meshheading:19335742-Isoxazoles,
pubmed-meshheading:19335742-Male,
pubmed-meshheading:19335742-Prospective Studies,
pubmed-meshheading:19335742-Receptors, Endothelin,
pubmed-meshheading:19335742-Survival Analysis,
pubmed-meshheading:19335742-Thiophenes,
pubmed-meshheading:19335742-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension.
|
pubmed:affiliation |
Cardiopulmonary Department, National Heart Institute, Mexico City, Mexico. tpulido@prodigy.net.mx
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|